Gilead Sciences today announced a definitive agreement to acquire Arcellx in a transaction valued at approximately USD 7.8 billion, marking a major step in Gilead’s expansion in next-generation cell therapy.
Sandoz has announced that the European Commission has granted marketing authorization for Ranluspec® (ranibizumab), a biosimilar developed by Lupin. The approval marks a significant step in expanding access to advanced ophthalmic therapies across Europe.
Harsh Bhardwaj1*, Sakshi Jain2, Raaz K Maheshwari3 1Assistant Professor, Department of Chemistry, Shri RK Patni Girls’ College, Kishangarh, Ajmer, Rajasthan, India
Diploma in pharmacy from a recognised institution/Board. Experience in dispensing and/or storage in dispensing of drugs in a reputed hospital or institution or in a drug store or a pharmaceutical concern. GMERS Medical College Hospital
MPharm in Pharmaceutics, Pharmaceutical analysis or pharmaceutical assurance. experience in clinical research or PG in any Health Science at Manipal Academy of Higher Education
B.Sc. Zoology/ Biotechnology/ Microbiology/ Life Science or equivalent and Three year research experience OR M.Sc. Zoology/ Biotechnology/ Microbiology/ Life Science or equivalent) from a recognized university.
Candidates having M.Sc. degree or equivalent in Life Science / Biochemistry / Biotechnology / Molecular Biology or any other related field with two years of research experience.
PhD with preceding Masters Degree of first class M.S / M.Pharm / M.Sc in chemistry or natural product chemistry or equivalent subject related to natural product.
Post Graduate Degree in Life Sciences / Pharmacy and Post Graduate Diploma in Clinical Research or Certificate course in clinical research from a recognized university/ institute. Tata Memorial Centre